Atlas Venture Fund Vii L P
10% Owner
Avg. Two Year Performance
No Purchase Track Record
88% Avg. Sale Return
37% Compound
Holdings: 1.34M shares
Last Three Months: 17-Feb-24 -- 16-May-24
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
17-May-22 -- 16-May-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions